You are here: Home / Sites / Fred Hutchinson Cancer Research Center / Dahlgren, Jackie R.

Dahlgren, Jackie R. (B.S.)

Staff, Fred Hutchinson Cancer Research Center, (206) 667-4170

Contact Information

Email: mailto:jdahlgre@fredhutch.org
Fax: (206) 667-5964

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.

Publications

Publication Name PubMed ID Journal
Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. 26343159 Gynecol. Oncol.
Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with Obesity. 27769113 J. Proteome Res.
Dermcidin expression is associated with disease progression and survival among breast cancer patients. 24562771 Breast Cancer Res. Treat.
Protein and glycomic plasma markers for early detection of adenoma and colon cancer. 27821646 Gut
Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study. 27745870 Surgery
JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors. 24764577 Cancer Immunol Res
Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. 23248253 J. Clin. Oncol.
Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening. 22750949 Cancer Prev Res (Phila)
Designing early detection programs for ovarian cancer. 22180403 Ann. Oncol.
Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer. 22962406 Cancer Epidemiol. Biomarkers Prev.
Potential role of HE4 in multimodal screening for epithelial ovarian cancer. 21917606 J. Natl. Cancer Inst.
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125. 22155417 Gynecol. Oncol.
Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study. 26319120 Breast Cancer Res. Treat.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

1100 Fairview Ave. N., M3-A837, P.O. Box 19024
Fred Hutchinson Cancer Research Center

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 09/27/2019
Thank you to everyone who made the 11th EDRN Scientific Workshop a success. The next EDRN Steering Committee Meeting is from Tuesday-Thursday, March 31-April 2, 2020 in Tempe, AZ.
Announcement



 
This icon signifies that something is happening and we kindly ask you to please wait